PSEUDOPOLYPOSIS

This adverse event was reported 145 times

These drugs are most commonly taken by patients reporting PSEUDOPOLYPOSIS:

# Drug Count
0 ADALIMUMAB 53
1 PREDNISONE 22
2 INFLIXIMAB 21
3 AZATHIOPRINE 17
4 VEDOLIZUMAB 17
5 METHOTREXATE SODIUM 11
6 METHOTREXATE 10
7 MESALAMINE 9
8 ADALIMUMAB-AATY 8
9 ADALIMUMAB-ADAZ 8
See all common drugs associated with PSEUDOPOLYPOSIS

PSEUDOPOLYPOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LACTULOSE SOLUTION USP, 10 G/15 ML 1 0.0099
1 USTEKINUMAB-AUUB 1 0.0057
2 ETRASIMOD 1 0.0006
3 DICLOFENAC SODIUM AND MISOPROSTOL 3 0.0005
4 AZATHIOPRINE SODIUM 1 0.0004
5 ADALIMUMAB-AFZB 1 0.0004
6 MESALAMINE 9 0.0003
7 TOFACITINIB CITRATE 4 0.0003
8 INFLIXIMAB-DYYB 1 0.0003
9 CHOLESTYRAMINE 3 0.0002
See all drugs enriched for association with PSEUDOPOLYPOSIS